189 related articles for article (PubMed ID: 20532840)
1. Evi-1 as a critical regulator of leukemic cells.
Goyama S; Kurokawa M
Int J Hematol; 2010 Jun; 91(5):753-7. PubMed ID: 20532840
[TBL] [Abstract][Full Text] [Related]
2. Evi-1 is a transcriptional target of mixed-lineage leukemia oncoproteins in hematopoietic stem cells.
Arai S; Yoshimi A; Shimabe M; Ichikawa M; Nakagawa M; Imai Y; Goyama S; Kurokawa M
Blood; 2011 Jun; 117(23):6304-14. PubMed ID: 21190993
[TBL] [Abstract][Full Text] [Related]
3. Pathogenetic significance of ecotropic viral integration site-1 in hematological malignancies.
Goyama S; Kurokawa M
Cancer Sci; 2009 Jun; 100(6):990-5. PubMed ID: 19385966
[TBL] [Abstract][Full Text] [Related]
4. Pbx1 is a downstream target of Evi-1 in hematopoietic stem/progenitors and leukemic cells.
Shimabe M; Goyama S; Watanabe-Okochi N; Yoshimi A; Ichikawa M; Imai Y; Kurokawa M
Oncogene; 2009 Dec; 28(49):4364-74. PubMed ID: 19767769
[TBL] [Abstract][Full Text] [Related]
5. Survivin modulates genes with divergent molecular functions and regulates proliferation of hematopoietic stem cells through Evi-1.
Fukuda S; Hoggatt J; Singh P; Abe M; Speth JM; Hu P; Conway EM; Nucifora G; Yamaguchi S; Pelus LM
Leukemia; 2015 Feb; 29(2):433-40. PubMed ID: 24903482
[TBL] [Abstract][Full Text] [Related]
6. Evi-1 is a critical regulator for hematopoietic stem cells and transformed leukemic cells.
Goyama S; Yamamoto G; Shimabe M; Sato T; Ichikawa M; Ogawa S; Chiba S; Kurokawa M
Cell Stem Cell; 2008 Aug; 3(2):207-20. PubMed ID: 18682242
[TBL] [Abstract][Full Text] [Related]
7. The MDS and EVI1 complex locus (MECOM) isoforms regulate their own transcription and have different roles in the transformation of hematopoietic stem and progenitor cells.
Maicas M; Vázquez I; Alis R; Marcotegui N; Urquiza L; Cortés-Lavaud X; Cristóbal I; García-Sánchez MA; Odero MD
Biochim Biophys Acta Gene Regul Mech; 2017 Jun; 1860(6):721-729. PubMed ID: 28391050
[TBL] [Abstract][Full Text] [Related]
8. The role of EVI1 in normal and leukemic cells.
Buonamici S; Chakraborty S; Senyuk V; Nucifora G
Blood Cells Mol Dis; 2003; 31(2):206-12. PubMed ID: 12972028
[TBL] [Abstract][Full Text] [Related]
9. The transcription factor Evi-1.
Hirai H
Int J Biochem Cell Biol; 1999 Dec; 31(12):1367-71. PubMed ID: 10641791
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of Evi-1 oncoprotein represses TGF-β signaling in colorectal cancer.
Deng X; Cao Y; Liu Y; Li F; Sambandam K; Rajaraman S; Perkins AS; Fields AP; Hellmich MR; Townsend CM; Thompson EA; Ko TC
Mol Carcinog; 2013 Apr; 52(4):255-264. PubMed ID: 22161860
[TBL] [Abstract][Full Text] [Related]
11. The EVI-1 gene--its role in pathogenesis of human leukemias.
Jółkowska J; Witt M
Leuk Res; 2000 Jul; 24(7):553-8. PubMed ID: 10867128
[TBL] [Abstract][Full Text] [Related]
12. EVI1 Interferes with Myeloid Maturation via Transcriptional Repression of Cebpa, via Binding to Two Far Downstream Regulatory Elements.
Wilson M; Tsakraklides V; Tran M; Xiao YY; Zhang Y; Perkins AS
J Biol Chem; 2016 Jun; 291(26):13591-607. PubMed ID: 27129260
[TBL] [Abstract][Full Text] [Related]
13. Primary acute myeloid leukemia cells with overexpression of EVI-1 are sensitive to all-trans retinoic acid.
Verhagen HJ; Smit MA; Rutten A; Denkers F; Poddighe PJ; Merle PA; Ossenkoppele GJ; Smit L
Blood; 2016 Jan; 127(4):458-63. PubMed ID: 26582376
[TBL] [Abstract][Full Text] [Related]
14. Thrombopoietin/MPL signaling confers growth and survival capacity to CD41-positive cells in a mouse model of Evi1 leukemia.
Nishikawa S; Arai S; Masamoto Y; Kagoya Y; Toya T; Watanabe-Okochi N; Kurokawa M
Blood; 2014 Dec; 124(24):3587-96. PubMed ID: 25298035
[TBL] [Abstract][Full Text] [Related]
15. The corepressor CtBP interacts with Evi-1 to repress transforming growth factor beta signaling.
Izutsu K; Kurokawa M; Imai Y; Maki K; Mitani K; Hirai H
Blood; 2001 May; 97(9):2815-22. PubMed ID: 11313276
[TBL] [Abstract][Full Text] [Related]
16. Global Identification of EVI1 Target Genes in Acute Myeloid Leukemia.
Glass C; Wuertzer C; Cui X; Bi Y; Davuluri R; Xiao YY; Wilson M; Owens K; Zhang Y; Perkins A
PLoS One; 2013; 8(6):e67134. PubMed ID: 23826213
[TBL] [Abstract][Full Text] [Related]
17. Dual functions of the AML1/Evi-1 chimeric protein in the mechanism of leukemogenesis in t(3;21) leukemias.
Tanaka T; Mitani K; Kurokawa M; Ogawa S; Tanaka K; Nishida J; Yazaki Y; Shibata Y; Hirai H
Mol Cell Biol; 1995 May; 15(5):2383-92. PubMed ID: 7739522
[TBL] [Abstract][Full Text] [Related]
18. Ecotropic viral integration site 1, stem cell self-renewal and leukemogenesis.
Kataoka K; Kurokawa M
Cancer Sci; 2012 Aug; 103(8):1371-7. PubMed ID: 22494115
[TBL] [Abstract][Full Text] [Related]
19. Oncogenic transcription factor Evi1 regulates hematopoietic stem cell proliferation through GATA-2 expression.
Yuasa H; Oike Y; Iwama A; Nishikata I; Sugiyama D; Perkins A; Mucenski ML; Suda T; Morishita K
EMBO J; 2005 Jun; 24(11):1976-87. PubMed ID: 15889140
[TBL] [Abstract][Full Text] [Related]
20. The t(3;21) fusion product, AML1/Evi-1, interacts with Smad3 and blocks transforming growth factor-beta-mediated growth inhibition of myeloid cells.
Kurokawa M; Mitani K; Imai Y; Ogawa S; Yazaki Y; Hirai H
Blood; 1998 Dec; 92(11):4003-12. PubMed ID: 9834202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]